Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 575, pseudogene (RN7SL575P) is a human genetic locus classified as a pseudogene, more specifically a non-coding RNA pseudogene[2][6][7]. It is one of hundreds of related sequences derived from the 7SL RNA, which is the RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex involved in the targeting and translocation of newly synthesized secretory and membrane proteins to the endoplasmic reticulum[5][9]. Pseudogenes like RN7SL575P arise from gene duplication or retrotransposition events, but by definition, they are not functional genes: they do not produce functional proteins or RNAs, nor are they recognized as therapeutic, enzymatic, receptor, or transporter targets[2][6][8]. Although certain pseudogenes can have regulatory roles (such as acting as molecular decoys for microRNAs or RNA-binding proteins), there is no evidence that RN7SL575P has any known biological or disease-associated role. It is not currently associated with any drugs, mechanisms of action, or use as a biomarker or therapeutic target[1][2][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 575, pseudogene (RN7SL575P).